De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Mindset Pharma Toekomstige groei
Future criteriumcontroles 2/6
Mindset Pharma's earnings are forecast to decline at 22% per annum while its annual revenue is expected to grow at 43.8% per year. EPS is expected to decline by 3.3% per annum.
Belangrijke informatie
-22.0%
Groei van de winst
-3.3%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 48.8% |
| Inkomstengroei | 43.8% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 30 Jun 2023 |
Recente toekomstige groei-updates
Geen updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2026 | 3 | -51 | -74 | N/A | 2 |
| 6/30/2025 | 8 | -34 | -35 | N/A | 2 |
| 6/30/2024 | 11 | -21 | -20 | N/A | 2 |
| 6/30/2023 | 9 | -9 | -5 | N/A | 2 |
| 3/31/2023 | 8 | -6 | -5 | -5 | N/A |
| 12/31/2022 | 8 | -5 | 6 | 6 | N/A |
| 9/30/2022 | 6 | -9 | 4 | 4 | N/A |
| 6/30/2022 | 4 | -17 | 0 | 0 | N/A |
| 3/31/2022 | 2 | -21 | -1 | -1 | N/A |
| 12/31/2021 | N/A | -21 | -12 | -12 | N/A |
| 9/30/2021 | N/A | -16 | -10 | -10 | N/A |
| 6/30/2021 | N/A | -12 | -8 | -8 | N/A |
| 3/31/2021 | N/A | -7 | -5 | -5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: MSET is forecast to remain unprofitable over the next 3 years.
Winst versus markt: MSET is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: MSET is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: MSET's revenue (43.8% per year) is forecast to grow faster than the Canadian market (6.8% per year).
Hoge groei-inkomsten: MSET's revenue (43.8% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if MSET's Return on Equity is forecast to be high in 3 years time